Screener / SEC EDGAR /CIK 0000790526 /10-K filed Mar 2, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Labs

RadNet, Inc. RDNT

Compare with peers Embed
FY2025 at a glance

Sales up 11.5%

XBRL, from each 10-K
RevenueStatements
$2.0B from $1.8B in FY2024
FY2016FY2025
Net incomeStatements
-$18.7M from $2.8M in FY2024
FY2016FY2025
EPS (diluted)Statements
$-0.25 from $0.04 in FY2024
FY2016FY2025
Operating marginStatements
3.0% from 5.7% in FY2024
FY2016FY2025
Total debtStatements
$1.1B from $1.0B in FY2024
FY2016FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (38)
EPS (ttm)
-0.29
Sales (ttm)
2.4B
Net income (ttm)
-22.4M
Sales growth
+11.5%
EPS growth
to a loss
Sales Q/Q
+22.1%
Free cash flow
-
Gross margin
-
Oper. margin
3.1%
Net margin
-0.9%
FCF margin
-
R&D / sales
-
Dividend
-
Debt/Eq
1.18
Curr. ratio
1.49
Cash
750.6M
Op. cash flow (ttm)
347.8M
EBITDA
214.1M
EBITDA margin
10.5%
Net debt
574.7M
Quick ratio
1.49
Interest cover
0.89
ROIC
1.4%
Goodwill / assets
24.1%
Oper. margin low 5y
3.0%
Tax rate
46.6%
Stock pay / sales
2.7%
Shares out.
78.8M
Shares Y/Y
+0.6%
Book / share
14.23
Cash / share
9.53
Sales / share
30.27
Asset turnover
0.56
Days sales out.
36
Sales 3Y CAGR
+12.6%
Sales 5Y CAGR
+13.7%

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2016 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 2.0B +9.7% a year Net income -18.7M
FY2016 revenue 884.5M · Revenues, 0001628280-19-003087 FY2016 net income 7.2M · NetIncomeLoss, 0001628280-19-003087 884.5M FY2016 FY2017 revenue 922.2M · Revenues, 0000790526-20-000003 FY2017 net income 53K · NetIncomeLoss, 0000790526-20-000003 922.2M FY2017 FY2018 revenue 975.1M · RevenueFromContractWithCustomerExcludingAssessedTax, 0000790526-21-000009 FY2018 net income 32.2M · NetIncomeLoss, 0000790526-21-000009 975.1M FY2018 FY2019 revenue 1.2B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000790526-22-000006 FY2019 net income 14.8M · NetIncomeLoss, 0000790526-22-000006 1.2B FY2019 FY2020 revenue 1.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000790526-23-000003 FY2020 net income -14.8M · NetIncomeLoss, 0000790526-23-000003 1.1B FY2020 FY2021 revenue 1.3B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-24-008035 FY2021 net income 24.7M · NetIncomeLoss, 0001628280-24-008035 1.3B FY2021 FY2022 revenue 1.4B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-25-009481 FY2022 net income 10.7M · NetIncomeLoss, 0001628280-25-009481 1.4B FY2022 FY2023 revenue 1.6B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-013337 FY2023 net income 3.0M · NetIncomeLoss, 0001628280-26-013337 1.6B FY2023 FY2024 revenue 1.8B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-013337 FY2024 net income 2.8M · NetIncomeLoss, 0001628280-26-013337 1.8B FY2024 FY2025 revenue 2.0B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-013337 FY2025 net income -18.7M · NetIncomeLoss, 0001628280-26-013337 2.0B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2016 to FY2025 (9 years).

Growth per share, FY2015 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Book value per share +33.5% a year FY2015 $0.81 to FY2025 $14.50, 10 years
Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 -$0.25$14.50-
Dec 31, 2024 $0.04$12.07-
Dec 31, 2023 $0.05$9.75-
Dec 31, 2022 $0.17$5.81-
Dec 31, 2021 $0.46$4.28-
Dec 31, 2020 -$0.29$3.26-
Dec 31, 2019 $0.29$3.02$0.60
Dec 31, 2018 $0.66$2.61$0.92
Dec 31, 2017 $0.00$1.30$1.71
Dec 31, 2016 $0.15$1.12$0.69
Dec 31, 2015 $0.17$0.81$0.53

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $1.0B
  • − All liabilities $2.4B
  • = Net current asset value -$1.4B
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $1.1B
  • − Goodwill $907.7M
  • − Other intangible assets $148.5M
  • = Tangible book value $33.7M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

RDNT against Health care peers

Among the 162 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+4.8%+20.2%
+11.5%72nd of 155 · median +10.5%
Net margin
-4.1%15.3%
-0.9%110th of 154 · median 6.8%
Return on equity
-5.2%18.5%
-2.0%104th of 144 · median 9.2%
Debt / equity (less is better)
1.160.42
1.1884th of 108 · median 0.69
RDNT and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
RDNT RadNet, Inc.$2.4B +11.5%--0.9%-2.0%-1.18
EXEL Exelixis, Inc.$2.5B +7.0%96.3%35.5%48.3%46.5%-
PRVA Privia Health Group, Inc.$2.4B +22.3%-1.4%4.3%--
CON Concentra Group Holdings Parent, Inc.$2.3B +13.9%-9.3%42.7%11.0%3.00
ENOV Enovis CORP$2.3B +6.7%61.3%-22.9%-35.3%3.0%0.84
TFX Teleflex Inc$2.3B +17.2%58.3%13.5%8.7%10.8%0.46
All 162 companies in the group

Where the $2.0B of revenue came from

by product, year to Dec 31, 2025

  • Commercial insurance $1.1B · 55%
  • Medicare $477.0M · 23%
  • Revenue under capitation arrangements $125.5M · 6%
  • Other payors $118.6M · 6%
  • Other revenue $65.0M · 3%
  • Other $124.0M · 6%

From the segment tables in the 10-K XBRL.

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances

Return on equity -1.7% FY2020: -9.0% net income ÷ equity
Net margin -0.9% FY2020: -1.4% profit per $ of sales: -18.7M ÷ 2.0B
Asset turnover 0.54× FY2020: 0.60× sales per $ of assets: 2.0B ÷ 3.8B
Leverage 3.45× FY2020: 10.78× assets per $ of equity: 3.8B ÷ 1.1B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    -0.9% vs 6.8%
  • Return on equity below 15%
    -2.0%
  • A profit in 8 of 10 years
Net margin, FY2016 to FY2025: 0.8% to -0.9%

Balance sheet

  • Interest covered less than 5 times
    Operating income is 0.9× interest expense
  • Debt larger than equity
    Debt / equity 1.18 on the latest balance sheet (peer median 0.69)
  • Current assets cover current liabilities
    Current ratio 1.49
Debt / equity at each year end, FY2016 to FY2025: 11.78 to 1.00

Cash and shareholders

  • Free cash flow positive in every one of 4 years
    $30.2M last year
  • Share count up over 5 years
    +47.7%
Free cash flow, FY2016 to FY2025: 32.4M to 30.2M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

$175.8M of principal due, schedule of Sep 30, 2026

Debt

Repayment schedule

From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Contract liabilities, current part

Paid in advance $16.1M cash received before delivery, not yet recognized as revenue, Sep 30, 2026 · +97.3% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

RDNT's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue2.0B
FY2016: 884.5MFY2017: 922.2MFY2018: 975.1MFY2019: 1.2BFY2020: 1.1BFY2021: 1.3BFY2022: 1.4BFY2023: 1.6BFY2024: 1.8BFY2025: 2.0B FY2017FY2019FY2021FY2023FY2025
Net income-18.7M
FY2016: 7.2MFY2017: 53KFY2018: 32.2MFY2019: 14.8MFY2020: -14.8MFY2021: 24.7MFY2022: 10.7MFY2023: 3.0MFY2024: 2.8MFY2025: -18.7M FY2017FY2019FY2021FY2023FY2025
Free cash flow30.2M
FY2016: 32.4MFY2017: 80.9MFY2018: 44.6MFY2019: 30.2MFY2020: -FY2021: -FY2022: -FY2023: -FY2024: -FY2025: - FY2017FY2019FY2021FY2023FY2025
Free cash flow after stock pay21.4M
FY2016: 26.6MFY2017: 74.1MFY2018: 36.9MFY2019: 21.4MFY2020: -FY2021: -FY2022: -FY2023: -FY2024: -FY2025: - FY2017FY2019FY2021FY2023FY2025
EPS (diluted)-0.25
FY2016: 0.15FY2017: 0.00FY2018: 0.66FY2019: 0.29FY2020: -0.29FY2021: 0.46FY2022: 0.17FY2023: 0.05FY2024: 0.04FY2025: -0.25 FY2017FY2019FY2021FY2023FY2025
Diluted shares75.2M
FY2016: 46.7MFY2017: 47.4MFY2018: 48.7MFY2019: 50.2MFY2020: 50.9MFY2021: 53.4MFY2022: 57.3MFY2023: 64.7MFY2024: 74.8MFY2025: 75.2M FY2017FY2019FY2021FY2023FY2025

The segments changed

10-K filed Mar 2, 2026

Compared with the 10-K of Mar 3, 2025: new segment Imaging Center; no longer reported: Total revenue.

When a company changes its segments, the years before are usually recast, so growth by segment is not comparable with what earlier 10-Ks showed. Found by comparing the segments with revenue in the last two 10-Ks (XBRL) and by the 10-K's own words, without AI.

Revenue by business segment

year to Dec 31, 2025
RevenueSharevs year before
Imaging Center 2.0B97.5% +10.9%
Digital Health 52.0M2.5% +39.3%

10-K 0001628280-26-013337, segment and revenue notes (XBRL).

Revenue by product or service

year to Dec 31, 2025
RevenueSharevs year before
Service fee revenue 1.9B93.8% +13.1%
Commercial insurance 1.1B55.4% +11.0%
Medicare 477.0M23.4% +16.3%
Revenue under capitation arrangements 125.5M6.2% -8.1%
Other payors 118.6M5.8% +13.1%
Other revenue 65.0M3.2% +39.2%
Medicaid 51.7M2.5% +15.6%
Workers' compensation/personal injury 44.7M2.2% +2.4%
Management fee revenue 27.5M1.3% +11.5%

10-K 0001628280-26-013337, segment and revenue notes (XBRL).

Revenue by region

year to Dec 31, 2025
RevenueSharevs year before
United States 2.0B98.3% +11.3%
Other countries 34.0M1.7% +24.7%

10-K 0001628280-26-013337, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Imaging Centers1.3B1.4B1.6B1.8B2.0B
Digital Health-16.6M26.1M37.3M52.0M
AI segment revenue1.4M4.4M12.5M--
Sum of segments1.3B1.4B1.6B1.8B2.0B

Operating income by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Imaging Centers-166.7M208.7M250.0M242.2M
Digital Health--1.0M7.5M-3.4M-15.3M

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Segments changed: FY2021, FY2022, FY2023 are in italics, as first reported under the earlier segments, so they are not comparable with the later years. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue884.5M922.2M975.1M1.2B1.1B1.3B1.4B1.6B1.8B2.0B
Cost of revenue775.8M802.4M867.5M999.7M------
Operating income38.5M50.0M30.9M69.9M35.7M82.6M46.4M98.7M104.6M62.0M
Interest expense21K40.6M43.5M48.0M45.9M48.8M50.8M64.5M79.8M69.9M
Pretax income12.4M26.4M38.5M29.7M-854K58.9M43.0M38.8M44.9M31.9M
Income tax4.4M24.3M394K6.2M895K14.6M9.4M8.5M6.0M14.9M
Net income7.2M53K32.2M14.8M-14.8M24.7M10.7M3.0M2.8M-18.7M
EPS (diluted)0.150.000.660.29-0.290.460.170.050.04-0.25
Diluted shares46.7M47.4M48.7M50.2M50.9M53.4M57.3M64.7M74.8M75.2M
Depreciation & amortization66.6M66.8M72.9M80.6M86.8M96.7M115.9M128.4M137.8M152.1M
EBITDA105.1M116.8M103.8M150.5M122.5M179.2M162.2M227.1M242.5M214.1M
Operating margin4.4%5.4%3.2%6.1%3.3%6.3%3.2%6.1%5.7%3.0%
Net margin0.8%0.0%3.3%1.3%-1.4%1.9%0.7%0.2%0.2%-0.9%
Revenue growth+9.3%+4.3%+5.7%+18.4%-7.1%+22.7%+8.7%+13.0%+13.2%+11.5%
EPS growth-11.8%-100%--56.1%to a loss--63.0%-70.6%-20.0%to a loss

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow91.6M142.2M116.8M104.3M233.8M149.5M146.4M220.9M233.0M298.8M
Capital spending59.3M61.3M72.2M74.2M------
Free cash flow32.4M80.9M44.6M30.2M------
Stock-based pay (added back)5.8M6.8M7.7M8.7M12.4M25.2M23.8M26.8M29.8M54.6M
Free cash flow after stock pay26.6M74.1M36.9M21.4M------
Debt raised476.5M-097.1M0717.3M148.0M0863.8M99.0M
Debt repaid469.1M196.7M33.8M40.7M43.3M619.5M53.8M41.1M--
Investing cash flow-65.5M-79.3M-146.7M-99.5M-126.2M-221.5M-246.9M-201.5M-233.1M-343.9M
Financing cash flow-5.9M-32.2M-10.9M25.0M-45.6M104.7M93.6M195.6M397.9M72.2M

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)5.8M6.8M7.7M8.7M12.4M25.2M23.8M26.8M29.8M54.6M
Stock-based pay / revenue0.7%0.7%0.8%0.8%1.2%1.9%1.7%1.7%1.6%2.7%
Operating lease cost---95.3M99.3M121.6M107.5M107.0M112.0M122.7M
Operating lease cash paid---95.9M89.8M110.3M108.0M101.5M103.2M105.3M
Finance lease principal paid---5.9M3.3M3.3M00--
Right-of-use assets---445.5M483.7M584.3M603.5M596.0M639.7M690.2M
Operating lease liabilities---482.1M528.9M643.1M661.7M661.1M712.6M768.9M
Finance lease liabilities---6.5M20K0----

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RDNT/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.